We recently published a case series in the peer-reviewed Wounds International journal showcasing Aiodine™, a novel iodine-based formulation developed by our team, in managing severe wounds. Aiodine™ effectively reduced infections without causing cytotoxicity, demonstrating broad-spectrum antimicrobial activity. Applied as a spray or wet compress for up to two weeks, it controlled inflammation and enhanced tissue repair, leading to significant improvement in pain and infection. These findings suggest Aiodine™ as a promising alternative to conventional disinfectants, with larger-scale trials planned for further validation.